激情综合色综合久久综合 I 国产欧美日韩一区二区三区 I 精品日本一区二区三区在线观看 I 日本公妇乱偷中文字幕 I 亚洲国产精品一区二区久久hs I 日本人做爰大片免费观看 I 精品国产精品久久一区免费式 I 1314成人免费看A片 I 男人和女人免费观看电视连续剧 I 手机福利视频 I melody在线高清免费观看 I 台湾成人娱乐网 I 韩国三级在线 I 老司机免费视频 I www四虎 I 97国产在线 I 日本动漫艳母 I 欧美日韩三区

Welcome to Linuo Group!HomeBusiness License
  • CN

  • WeChat

  • Mobile Site

  • Search

力諾資訊

Hongjitang holds National Forum for Diagnosis and Treatment of Interstitial Lung Disease through the Integrated Approach of TCM and Western Medicine

2023.07.13

On July 9, the National Forum for Diagnosis and Treatment of Interstitial Lung Disease through the Integrated Approach of TCM and Western Medicine was held at Hongjitang.

Interstitial lung disease (ILD) is one of the four major respiratory diseases with rising prevalence worldwide. The newly founded Committee for Research on ILD Prevention and Treatment Technology unter Shandong Traditional Chinese Medicine Association (STCMA) shall serve as a platform for prescription sharing to improve the effectiveness of ILD treatment with TCM, meanwhile promoting the R&D of new TCM drugs and standardization of diagnosis and treatment of the disease.

During the forum, TCM experts had in-depth exchanges from different perspectives, such as the therapeutic status quo of interstitial lung diseases, epidemiology and medication administration, with focus on Jinbei Koufuye.

Jinbei Koufuye is a TCM product for the treatment of idiopathic pulmonary fibrosis. It shows great clinical efficacy and less adverse reactions, helping improve the life quality of patients. The Development of Jinbei Koufuye and its Application in Respiratory Diseases, a research project carried out by Hongjitang TCM Institute, won the first prize of the first Shandong Traditional Chinese Medicine Industry Science and Technology Award.